SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-007849
Filing Date
2022-05-05
Accepted
2022-05-05 16:17:11
Documents
15
Period of Report
2022-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K onct-20220505.htm   iXBRL 8-K 68335
2 EX-99.1 onct-ex99_1.htm EX-99.1 118373
3 GRAPHIC img119983317_0.jpg GRAPHIC 7888
  Complete submission text file 0000950170-22-007849.txt   357358

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT onct-20220505_lab.xml EX-101.LAB 16773
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT onct-20220505.xsd EX-101.SCH 2928
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT onct-20220505_def.xml EX-101.DEF 13600
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT onct-20220505_pre.xml EX-101.PRE 13617
9 EXTRACTED XBRL INSTANCE DOCUMENT onct-20220505_htm.xml XML 6181
Mailing Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 22896524
SIC: 2834 Pharmaceutical Preparations